Diagnosis and medical treatment of fungal keratitis
A significant trend is a move away from yeast infections and toward filamentous fungal keratitis over the past decade
Matthew Burton PhD, London, UK, gave the keynote speech on infectious keratitis at the annual Cornea Day, during the 21st ESCRS Winter Meeting in Maastricht, The Netherlands.
“A significant trend is a move away from yeast infections and toward filamentous fungal keratitis over the past decade, which currently cause 70% of fungal infections in our hospital,” said Dr Burton. A reverse trend has been noted in candida infections.
Regarding the diagnostic approach, Dr Burton advised delegates to focus on potential risk factors, including contact lens use, ocular surface disease, trauma, surgery and especially tropical travel.
“Travel history is often overlooked, despite it’s great importance,” said Dr Burton. The closer the patient has travelled to the equator, the higher the proportion of fungal keratitis.
Diagnostics should include in vivo confocal microscopy (IVCM), scrape for microbiology, PCR and biopsy.
“IVCM can be a very valuable modality, particularly for deeper infections not amenable to the other diagnostic approaches,” he said.
IVCM can be a very valuable modality, particularly for deeper infections not amenable to the other diagnostic approaches
Dr Burton also reviewed the evidence that guided his approach to treatment. The most valuable studies compared topical treatments such as natamycin, voriconazole and chlorhexidine, as well as oral and intrastromal voriconazole. Dr Burton reminded delegates to be particularly careful with oral voriconazole, which can lead to fatal hepatotoxicity.
“Despite the potential for success of medical treatments, don’t be afraid to consider surgery with there’s no treatment response or when the limbus becomes involved,” he concluded.EUROTIMES Diagnosis and medical treatment of fungal keratitis LATEST
Atropine halts myopia progressionTuesday, June 13, 2017
A low-dose formulation of atropine slowed the progression of myopia for a majority of treated children over a two-year period with no adverse side effects, according to a study presented at the European Society of Ophthalmology (SOE) 2017 Congress in Barcelona. “Our experience in this small study shows that atropine seems to be safe […]
Ophthalmic effects of long-term spaceflightMonday, May 8, 2017
Retired astronaut and US Navy Captain Scott Kelly was one of the keynote speakers at the 2017 ASCRS/ASAO Congress. Among the topics he discussed in a wide-ranging speech looking back on his career, was the ophthalmic effects of long-term spaceflight, including increased cerebral fluid pressure, optic nerve swelling and retinal folds. Captain Kelly lived […]
Accelerated corneal crosslinking worksMonday, May 8, 2017
An accelerated corneal crosslinking (CXL) approach appears to be safe for treating patients with progressive keratoconus, and delivers comparable visual and corneal biomechanical results to the standard Dresden protocol while reducing treatment time 60 minutes to 18 minutes, Thomas Kohnen MD, PhD, told the 2017 ASCRS•ASOA Symposium & Congress in Los Angeles, USA. In a retrospective […]
Better visual acuity with FLACSSunday, May 7, 2017
Karl Stonecipher MD Patients treated with femtosecond laser-assisted cataract surgery (FLACS) had significantly better uncorrected visual acuity (UCVA) three hours after surgery than those treated with conventional phaco cataract surgery, Karl Stonecipher MD told the 2017 ASCRS•ASOA Symposium & Congress in Los Angeles, USA. Mean UCVA for 1,015 FLACS patients was 20/32 compared with 20/50 […]
Which MIGS device to use in a patient with glaucoma?Tuesday, February 21, 2017
In general, MIGS devices should be restricted to patients with mild-to moderate glaucoma controlled by medication.
Handling complicationsFriday, February 17, 2017
Catarina Pedrosa MD Catarina Pedrosa MD, Lisbon, Portugal, advised delegates attending the 21st ESCRS Winter Meeting in Maastricht, The Netherlands, on how to avoid problems when performing cataract surgery in posterior polar cataract, and how to solve them once they occur. Dr Pedrosa was speaking during a session entitled ‘The Usual Suspects: How to Handle Your […]
Diagnosis and medical treatment of fungal keratitisThursday, February 16, 2017
Matthew Burton PhD, London, UK, gave the keynote speech on infectious keratitis at the annual Cornea Day, during the 21st ESCRS Winter Meeting in Maastricht, The Netherlands. “A significant trend is a move away from yeast infections and toward filamentous fungal keratitis over the past decade, which currently cause 70% of fungal infections in our hospital,” […]
The proud history of the ‘Low Countries’ in the history of opticsThursday, February 16, 2017
The ‘Low Countries’ – Belgium and The Netherlands – have a played a prominent role in the history of optics from the Renaissance up to the present day, said Frans Van de Velde MD, PhD, Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, USA. In a lecture he delivered at the 21st ESCRS Winter Meeting […]
Long-term complications of refractive lens exchangeWednesday, February 15, 2017
What happens to our patients’ eyes after refractive lens exchange (RLE)? This was the question addressed by Oliver Findl MD, Vienna, Austria, during the session on ‘Long-Term Complications of Refractive Surgery’ at the 21st ESCRS Winter Meeting in Maastricht, The Netherlands. “The three primary problems we have to worry about are cystoid macular edema, posterior capsular opacity […]
Measuring the biomechanics of the corneaMonday, February 13, 2017
The correct measurement of the cornea’s biomechanical properties can have significant clinical applications, from the measurement of intraocular pressure to the evaluation of progression in glaucoma and keratoconus. Cynthia Roberts, Ohio, USA, discussed the details of these properties at the 21st ESCRS Winter Meeting in Maastricht, The Netherlands. The goal is to distinguish the effects […]